Institutional shares held 77.1 Million
139K calls
253K puts
Total value of holdings $609M
$1.1M calls
$2M puts
Market Cap $569M
73,461,104 Shares Out.
Institutional ownership 104.94%
# of Institutions 175


Latest Institutional Activity in DAWN

Top Purchases

Q1 2025
Hennion & Walsh Asset Management, Inc. Shares Held: 138K ($1.07M)
Q1 2025
Wealth Enhancement Advisory Services, LLC Shares Held: 11.2K ($86.3K)
Q1 2025
Pallas Capital Advisors LLC Shares Held: 11K ($85.2K)
Q1 2025
Rhumbline Advisers Shares Held: 81.8K ($633K)
Q1 2025
Exchange Traded Concepts, LLC Shares Held: 14.7K ($114K)

Top Sells

Q1 2025
Sg Americas Securities, LLC Shares Held: 34.4K ($266K)
Q1 2025
Gamma Investing LLC Shares Held: 283 ($2.19K)
Q1 2025
Farther Finance Advisors, LLC Shares Held: 1 ($7.74)
Q4 2024
Ra Capital Management, L.P. Shares Held: 5.76M ($44.5M)
Q4 2024
Goldman Sachs Group Inc Shares Held: 472K ($3.66M)

About DAWN

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.


Insider Transactions at DAWN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
445K Shares
From 5 Insiders
Exercise of conversion of derivative security 203K shares
Bona fide gift 242K shares
Sell / Disposition
626K Shares
From 6 Insiders
Open market or private sale 384K shares
Bona fide gift 242K shares

Track Institutional and Insider Activities on DAWN

Follow Day One Biopharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

News

Receive news related to Day One Biopharmaceuticals, Inc.

Track Activities on DAWN